✦ LIBER ✦

A preliminary study of urinary transferrin as a marker for prostatic cancer

✍ Scribed by Conchita Fernandez; Nader Rifai; Alien S. Wenger; Don D. Mickey; Lawrence M. Silverman

Book ID: 115825260
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 354 KB
Volume: 161
Category: Article
ISSN: 0009-8981
DOI: 10.1016/0009-8981(86)90018-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Endoglin (CD105) as a urinary and serum

Endoglin (CD105) as a urinary and serum marker of prostate cancer

✍ Kazutoshi Fujita; Charles M. Ewing; David Y.S. Chan; Leslie A. Mangold; Alan W. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 105 KB

## Abstract We have previously shown that endoglin (CD105) is upregulated in prostatic fluid of men with large volume prostate cancer. We chose to assess endoglin levels in urine and serum from men with prostate cancer or at increased risk for the disease: Urine samples were collected after digital

169 Lymphangiogenesis as a Prognostic Ma

169 Lymphangiogenesis as a Prognostic Marker in Breast Cancer Using D2-40 as Lymphatic Endothelial Marker – A Preliminary Study

✍ A. Kumar; V. Pandey; M.A. Ansari; V. Srivastava; M. Kumar 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Ca 27–29: A new marker for breast cancer

Ca 27–29: A new marker for breast cancer: Preliminary study

✍ M.G. Reale; M. Di Seri; M. Sciò; A. Manna; G.G. Marchei; F. Simeoni; P. Marchei 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 174 KB

Age-Specific Reference Ranges for Prosta

Age-Specific Reference Ranges for Prostate-Specific Antigen as a Marker for Prostate Cancer

✍ Hans-Joachim Luboldt; Joachim F. Schindler; Herbert Rübben 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 247 KB

Prostate-specific human kallikrein (hK2)

Prostate-specific human kallikrein (hK2) as a novel marker for prostate cancer

✍ Charles Y. F. Young; Thomas Seay; Kristine Hogen; M. Cristine Charlesworth; Patr 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 739 KB

Calcitonin as a marker for bronchogenic

Calcitonin as a marker for bronchogenic cancer. A prospective study

✍ Omega L. Silva; Lawrence E. Broder; John L. Doppman; Richard H. Snider; Charles 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 397 KB 👁 1 views

A prospective study was done of serum calcitonin (HCT) levels in 61 patients with bronchogenic cancer. Initially, 52% of patients had hypercalcitonemia. Hypercalcitonemia was not confined to patients with any particular histologic type. Seventy-eight percent of those with high calcitonin remained no